Orris

Pumping & priming effect of vaporisers & modifications to prevent it .Physics & laws applied to anaesthesia delivery systems. Uptake & distribution of volatile anaesthesia

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Searching the Web

uptake distribution volatile anaesthetic FA/FI ratio Eger factors affecting alveolar concentration anaesthesia physics

Loading Image
Finding Sources
Searching Images

FA FI ratio volatile anaesthetic uptake graph inhalation induction curve

This composite diagnostic image illustrates a first-in-human 18F-pretomanid Positron Emission Tomography (PET) study. Panel A shows a coronal CT scan of the head, neck, and upper torso for anatomical reference. Panel B is a time-activity curve graph plotting 18F-pretomanid PET uptake (%ID/g) against time (0-200 minutes) for three compartments: plasma (blue), brain (red), and lungs (green). The graph demonstrates higher initial brain uptake with a slower clearance rate compared to the rapid decline in plasma. Panel C displays Area Under the Curve (AUC) heatmaps for the brain and lungs, overlaid on anatomical sections. The heatmaps use a rainbow color scale (blue-to-red) to indicate radiotracer distribution, showing heterogeneous uptake in lung tissue and specific distribution patterns in the brain parenchyma. Panel D provides a quantitative comparison of the tissue-to-plasma AUC ratios (4-200 min), indicating a brain-to-plasma ratio of 2.39 and a lung-to-plasma ratio of 1.09. This figure demonstrates the pharmacokinetic profile and biodistribution of 18F-pretomanid, a radiolabeled antitubercular agent, particularly highlighting its penetration into the central nervous system and pulmonary system.

This composite diagnostic image illustrates a first-in-human 18F-pretomanid Positron Emission Tomography (PET) study. Panel A shows a coronal CT scan of the head, neck, and upper torso for anatomical reference. Panel B is a time-activity curve graph plotting 18F-pretomanid PET uptake (%ID/g) against time (0-200 minutes) for three compartments: plasma (blue), brain (red), and lungs (green). The graph demonstrates higher initial brain uptake with a slower clearance rate compared to the rapid decline in plasma. Panel C displays Area Under the Curve (AUC) heatmaps for the brain and lungs, overlaid on anatomical sections. The heatmaps use a rainbow color scale (blue-to-red) to indicate radiotracer distribution, showing heterogeneous uptake in lung tissue and specific distribution patterns in the brain parenchyma. Panel D provides a quantitative comparison of the tissue-to-plasma AUC ratios (4-200 min), indicating a brain-to-plasma ratio of 2.39 and a lung-to-plasma ratio of 1.09. This figure demonstrates the pharmacokinetic profile and biodistribution of 18F-pretomanid, a radiolabeled antitubercular agent, particularly highlighting its penetration into the central nervous system and pulmonary system.

This monochrome clinical photograph demonstrates a specific technique for inhalation anesthesia induction, referred to as the 'snorkel breathing technique.' The image shows a patient in a supine position, holding a modified anesthetic breathing circuit directly between their lips. The apparatus consists of a clear mouthpiece interface connected to a Y-piece or T-shaped connector, which features a capped sampling port. This is attached to flexible, white corrugated tubing leading to a Heat and Moisture Exchanger (HME) filter or similar cylindrical circuit component, labeled with directional flow indicators ('Pt'). The patient’s facial features, including the nose and mouth, are visible, illustrating the oral interface that bypasses the traditional full-face mask. A gloved hand of a clinician is visible, stabilizing the circuit near the patient's face. This setup is utilized in anesthesia for patients with specific phobias or preferences, allowing for the delivery of volatile anesthetic agents like sevoflurane through controlled oral breathing during the induction phase.

This monochrome clinical photograph demonstrates a specific technique for inhalation anesthesia induction, referred to as the 'snorkel breathing technique.' The image shows a patient in a supine position, holding a modified anesthetic breathing circuit directly between their lips. The apparatus consists of a clear mouthpiece interface connected to a Y-piece or T-shaped connector, which features a capped sampling port. This is attached to flexible, white corrugated tubing leading to a Heat and Moisture Exchanger (HME) filter or similar cylindrical circuit component, labeled with directional flow indicators ('Pt'). The patient’s facial features, including the nose and mouth, are visible, illustrating the oral interface that bypasses the traditional full-face mask. A gloved hand of a clinician is visible, stabilizing the circuit near the patient's face. This setup is utilized in anesthesia for patients with specific phobias or preferences, allowing for the delivery of volatile anesthetic agents like sevoflurane through controlled oral breathing during the induction phase.

This composite educational graphic details the kinetics and visualization of gadoxetate disodium enhancement in metastatic castration-resistant prostate cancer (mCRPC). Panel A is a line graph showing the mean Contrast Enhancement Ratio (CER) over a 60-minute timeline. The curve demonstrates a rapid rise from pre-contrast levels to a peak at 10 minutes, followed by a decline at 20 minutes, then a sustained plateau phase through 60 minutes, indicating contrast retention in metastatic lesions. Panel B features a side-by-side comparison of axial T1-weighted MRI scans of the pelvis. Image (a) shows the pre-contrast baseline with a dark, hypointense lesion in the left ilium (white arrow). Image (b) shows the same lesion 60 minutes post-injection, now appearing hyperintense (brighter) due to delayed gadoxetate disodium uptake. The material illustrates the potential for hepatobiliary contrast agents to evaluate extrahepatic mCRPC lesions, likely mediated by OATP1B3 expression.

This composite educational graphic details the kinetics and visualization of gadoxetate disodium enhancement in metastatic castration-resistant prostate cancer (mCRPC). Panel A is a line graph showing the mean Contrast Enhancement Ratio (CER) over a 60-minute timeline. The curve demonstrates a rapid rise from pre-contrast levels to a peak at 10 minutes, followed by a decline at 20 minutes, then a sustained plateau phase through 60 minutes, indicating contrast retention in metastatic lesions. Panel B features a side-by-side comparison of axial T1-weighted MRI scans of the pelvis. Image (a) shows the pre-contrast baseline with a dark, hypointense lesion in the left ilium (white arrow). Image (b) shows the same lesion 60 minutes post-injection, now appearing hyperintense (brighter) due to delayed gadoxetate disodium uptake. The material illustrates the potential for hepatobiliary contrast agents to evaluate extrahepatic mCRPC lesions, likely mediated by OATP1B3 expression.

Reading File
Reading File
Reading File
Loading Image
I now have comprehensive content from all three sources. Let me compose the full detailed answer.

Pumping & Priming Effect of Vaporisers, Physics of Anaesthesia Delivery, and Uptake & Distribution of Volatile Anaesthetics

PART 1: PUMPING AND PRIMING EFFECT OF VAPORISERS

Definition and Mechanism

The pumping effect refers to delivery of a higher-than-expected anaesthetic concentration from a variable bypass vaporiser, caused by intermittent back pressure. It occurs during:
  • Positive-pressure (IPPV) ventilation
  • Use of the oxygen flush valve
Mechanism (retrograde pressure transmission): During the inspiratory phase of IPPV, pressure is transmitted retrograde from the breathing circuit through the common gas outlet into both the bypass chamber and the vaporizing chamber - gas molecules are compressed in both. When back pressure is suddenly released during the expiratory phase, vapour exits the vaporizing chamber via two routes simultaneously:
  1. Antegrade through the normal outlet
  2. Retrograde back through the vaporizing chamber inlet into the bypass chamber
This retrograde flow carries extra anaesthetic vapour into the bypass stream, producing a higher output than the dial setting. The lower output resistance of the bypass chamber compared to the vaporizing chamber drives the retrograde flow.
(Barash Clinical Anesthesia 9e, p.1977; Miller's Anesthesia 10e, p.2288)

Factors That Worsen the Pumping Effect

FactorEffect
Low fresh gas flow ratesWorse effect
Low dial concentration settingWorse
Low level of liquid anaesthetic in chamberWorse
Rapid respiratory rateWorse
High peak inspiratory pressureWorse
Rapid pressure decrease during expirationWorse

The Priming Effect

The priming effect is a related phenomenon. It refers to the initial surge of anaesthetic vapour at a higher-than-intended concentration when gas flow begins through a vaporiser that has been pressurised (e.g., after the oxygen flush). The vaporising chamber has been "primed" with pressurised vapour-laden gas which surges forward as pressure normalises.

Modifications to Prevent the Pumping Effect

Modern variable bypass vaporisers incorporate several design features to minimise this:

1. Smaller Vaporizing Chamber Volume

Contemporary chambers are much smaller than older models. A smaller chamber contains less vapour that can be retrogressively discharged into the bypass stream during expiration. (Barash 9e, p.1977)

2. Long Spiral / Serpentine / Labyrinth Inlet Tube

Some vaporisers (e.g., Dräger Vapor series) have a long coiled or labyrinth passage as the inlet to the vaporizing chamber. When pressure in the vaporizing chamber is released, vapour cannot travel back through the lengthy tortuous path into the bypass chamber. This serpentine passage also dampens pressure fluctuations and compensates for variations in gas supply pressure. (Miller's 10e, p.2289)

3. Extensive Baffle System

An internal baffle system within the vaporizing chamber disrupts retrograde gas flow, preventing back-diffusion of vapour into the bypass stream.

4. Machine Outlet Check Valve (One-Way Valve)

A non-return/check valve placed downstream of the vaporisers (between the vaporiser outlet and the breathing circuit inlet) prevents retrograde pressure transmission from the breathing circuit reaching the vaporiser at all. This is the most definitive prevention strategy. (Miller's 10e, p.2289)
Diagram showing the expansion element, pressure compensation serpentine inlet, vaporizing chamber, and outlet check valve:
Dräger-type vaporiser with expansion element and pressure compensation
Figure: Simplified schematic of a Dräger Vapor-type vaporiser showing the expansion element for temperature compensation and the serpentine pressure-compensation inlet to the vaporising chamber. (Barash 9e, Fig. 25-24)
Variable bypass vaporiser - temperature compensation bimetallic strip, baffle, and machine outlet check valve
Figure: Temperature compensation via bimetallic strip. Note baffle system, wick, machine outlet check valve - all of which also help mitigate the pumping effect. (Miller's 10e, Fig. 20.22)

PART 2: PHYSICS AND LAWS APPLIED TO ANAESTHESIA DELIVERY SYSTEMS

These fundamental physical laws govern the behaviour of anaesthetic gases and vapours in the delivery system:

Gas Laws

1. Boyle's Law

P₁V₁ = P₂V₂ (at constant temperature)
Pressure and volume are inversely proportional. Applied in:
  • Compressed gas cylinders (high-pressure O₂ cylinders: contents calculable from gauge pressure)
  • Breathing bags and bellows - as circuit pressure rises, volume decreases
  • The pumping effect itself - gas is compressed in the vaporizing chamber under back-pressure, then expands as pressure drops

2. Charles' Law

V/T = constant (at constant pressure)
Volume is directly proportional to absolute temperature. Applied in:
  • Vaporiser output varies with temperature - as temperature rises, SVP rises and more vapour is produced (hence need for temperature compensation)
  • Gas volume delivered from bellows/reservoir bags changes with ambient temperature

3. Gay-Lussac's Law (Pressure Law)

P/T = constant (at constant volume)
Pressure is proportional to absolute temperature. Applied in:
  • Cylinder pressure increases when warmed - oxygen cylinders must not be stored near heat sources
  • Pressure regulators must account for temperature-related pressure changes

4. Dalton's Law of Partial Pressures

P_total = P₁ + P₂ + P₃ + ...
Total pressure of a gas mixture equals the sum of partial pressures of component gases. Applied in:
  • FiO₂ calculation: O₂ partial pressure = FiO₂ × atmospheric pressure (e.g., 0.21 × 101.3 kPa = 21.3 kPa at sea level)
  • Calculating delivered anaesthetic partial pressures
  • Gas mixing at the rotameter manifold - each gas contributes its partial pressure independently
  • MAC (minimum alveolar concentration) is expressed as a partial pressure concept

5. Avogadro's Law

Equal volumes of all gases at the same temperature and pressure contain equal numbers of molecules. Applied in:
  • Flowmeter calibration - each gas rotameter is calibrated individually since gas density differs
  • 1 gram molecular weight of any gas occupies 22.4 L at STP

6. Henry's Law

The amount of gas dissolved in a liquid is proportional to the partial pressure of the gas above it. C = k × P
Applied in:
  • Blood/gas partition coefficient: the amount of anaesthetic dissolving in blood is proportional to its alveolar partial pressure
  • Higher solubility (higher λ) → more dissolved → slower rise in alveolar partial pressure → slower induction
  • Used to understand uptake from alveoli into pulmonary capillary blood

7. Fick's Law of Diffusion

Rate of diffusion ∝ (Area × Concentration gradient × Solubility) / (Thickness × √Molecular weight)
Applied in:
  • Diffusion of anaesthetic gases across the alveolar-capillary membrane
  • Diffusion hypoxia after N₂O discontinuation (Fink effect): large volume of N₂O diffuses out of blood into alveoli, diluting O₂

8. Graham's Law

Rate of diffusion of a gas ∝ 1 / √molecular weight
Applied in:
  • Rotameter calibration - lighter gases like H₂ and He flow faster than heavier ones through a tube
  • Understanding differential gas flow through variable orifice flowmeters

9. Poiseuille's Law

Flow ∝ r⁴ × ΔP / (8ηL)
Flow through a tube is proportional to the 4th power of the radius and directly proportional to pressure gradient; inversely proportional to viscosity and tube length. Applied in:
  • Gas flow through the anaesthetic machine tubing, flowmeters, and breathing circuits
  • Explains why small reductions in tube radius (e.g., from secretions or kinking) dramatically reduce flow
  • Laminar flow through rotameter tubes at low flow rates

10. Reynolds' Number & Turbulent Flow

Re = ρvd/η
  • Low Re (<2000): laminar flow (Poiseuille applies) - flow dependent on viscosity
  • High Re (>4000): turbulent flow - flow dependent on density
  • Applied in: gas flow through rotameters (laminar at bottom, turbulent at top of bobbin), airway resistance during high-flow delivery, Venturi masks

11. Bernoulli Effect / Venturi Principle

As gas velocity increases through a constriction, lateral pressure drops. Applied in:
  • Venturi masks (air entrainment)
  • Injector (Venturi) in the anaesthetic machine for driving bellows
  • Nebuliser function
  • Oxygen therapy devices

12. Laplace's Law

P = 2T/r (spherical) or P = T/r (cylindrical)
Pressure within a sphere is inversely proportional to radius. Applied in:
  • Alveolar stability: smaller alveoli tend to collapse (higher pressure), counteracted by surfactant
  • Understanding why a small balloon empties into a large one when connected
  • Compliance of anaesthetic bags and breathing circuit components

13. The Ideal Gas Law

PV = nRT
Combines Boyle's, Charles', and Avogadro's laws. Applied in:
  • Calculating gas quantities in cylinders and pipelines
  • Understanding how temperature and pressure affect delivered gas volumes

Vapour Pressure and Vaporiser Physics

Saturated Vapour Pressure (SVP): Every volatile agent has a characteristic SVP at a given temperature. This drives vaporiser design. The splitting ratio of a variable bypass vaporiser is calculated using:
Splitting ratio = SVP / (Patm - SVP) × (desired output concentration)
Temperature compensation is achieved by:
  • Bimetallic strip (e.g., Tec series vaporisers): two metals with different thermal expansion coefficients bend toward the bypass channel as temperature rises, directing more flow through the bypass and less through the vaporizing chamber
  • Expansion element (Dräger Vapor series): an aneroid-type element expands with heat to divert gas toward the bypass

PART 3: UPTAKE AND DISTRIBUTION OF VOLATILE ANAESTHETICS

The central concept is the FA/FI ratio: the ratio of alveolar anaesthetic concentration (FA) to inspired concentration (FI). A higher FA/FI ratio means faster induction. This ratio starts at zero and rises toward 1.0 with time.

DELIVERY TO THE ALVEOLI

Factors increasing delivery (and therefore rate of rise of FA/FI):

1. Inspired Concentration (FI)

Higher FI directly raises FA. Additionally, a higher FI increases the rate of rise of FA/FI via two special effects (see below).

2. Alveolar Ventilation

  • Increased minute ventilation speeds up induction by replacing anaesthetic taken up by the blood
  • The effect is greatest for soluble agents (e.g., halothane, isoflurane) because these are subject to large blood uptake; increasing ventilation can partially overcome this
  • For insoluble agents (e.g., desflurane, N₂O), FA/FI rises rapidly regardless of ventilation as uptake is minimal

3. Functional Residual Capacity (FRC)

  • FRC dilutes the inspired anaesthetic in the alveoli
  • Large FRC slows induction (adults vs children)
  • Higher alveolar ventilation : FRC ratio = faster induction (children have ratio 5:1 vs adults 1.5:1)

4. Circuit Characteristics

  • Circuit volume: a large circuit volume dilutes and delays delivery
  • Fresh gas flow rate: higher FGF speeds equilibration and reduces rebreathing
  • Solubility of agent into rubber/plastic: older circuits absorbed volatile agents, slowing delivery

UPTAKE FROM ALVEOLI

This is the primary factor opposing a rise in FA/FI. Uptake (U) is given by:
U = λb/g × Q̇ × (PA - Pv̄)
Where:
  • λb/g = blood/gas partition coefficient (solubility)
  • Q̇ = cardiac output (= alveolar blood flow if no shunt)
  • PA - Pv̄ = alveolar to mixed venous partial pressure difference

A. Solubility (Blood/Gas Partition Coefficient, λ)

AgentBlood/Gas λSpeed of Induction
Desflurane0.42Very fast
Nitrous oxide0.47Very fast
Sevoflurane0.65Fast
Isoflurane1.4Moderate
Halothane2.4Slower
  • A high λ means more anaesthetic dissolves in blood → blood acts as a "sink" → alveolar partial pressure rises slowly → slow induction
  • A low λ means blood is quickly saturated → FA rises quickly → fast induction
  • High postprandial lipidaemia increases blood solubility; anaemia decreases it
(Morgan & Mikhail Clinical Anesthesiology 7e, p.281-282)

B. Cardiac Output

  • High CO → more blood passes through lungs → more anaesthetic removed from alveoli → FA rises slowly → slow induction
  • Low CO (e.g., shock, heart failure) → less uptake → FA rises rapidly → risk of anaesthetic overdose with soluble agents
  • This effect is pronounced for soluble agents and minimal for insoluble agents
  • Clinical implication: low CO states require reduced inspired concentrations of soluble agents

C. Alveolar - Venous Partial Pressure Difference (PA - Pv̄)

  • At induction, venous blood returns essentially free of anaesthetic (Pv̄ ≈ 0), so the gradient is maximal
  • As tissues equilibrate, venous partial pressure rises, gradient falls, uptake slows, and FA/FI ratio rises more quickly
  • This explains the characteristic hyperbolic shape of FA/FI curves: rapid initial rise, then plateau

SPECIAL PHENOMENA

Concentration Effect

When a gas is given at very high inspired concentration (mainly relevant for N₂O), two things happen:
  1. Concentrating effect: As N₂O is absorbed, total alveolar volume shrinks, but the remaining N₂O occupies a larger fraction of the smaller volume - raising its concentration above expected
  2. Augmented inflow effect: Reduction in alveolar volume creates a slight negative pressure drawing more fresh gas in from the circuit, which also carries more N₂O (and any co-administered volatile agent)
Result: FA/FI rises faster than predicted by simple uptake calculations. (Morgan & Mikhail 7e, p.281)

Second Gas Effect

When N₂O is given at high concentration with a potent volatile agent (e.g., sevoflurane):
  • Rapid uptake of large volumes of N₂O concentrates the volatile agent in alveoli
  • This accelerates the rise of FA/FI for the volatile agent beyond what would occur with oxygen alone
  • Clinically: N₂O co-administration speeds induction with volatile agents

TISSUE DISTRIBUTION (Compartmental Model)

After uptake into the blood, anaesthetic is distributed to tissues. The rate of equilibration with each tissue group depends on:
  • Tissue blood flow (perfusion)
  • Tissue-blood partition coefficient
  • Tissue volume
Tissue Group% Body Mass% Cardiac OutputExamples
Vessel-rich group (VRG)10%75%Brain, heart, liver, kidney
Muscle group50%20%Skeletal muscle
Fat group20%6%Adipose tissue
Vessel-poor group (VPG)20%<1%Bone, tendons, cartilage
Sequence of equilibration:
  1. VRG equilibrates rapidly (high flow, moderate volume) - this is why anaesthesia is achieved quickly in the brain
  2. Muscle group equilibrates over 20-40 minutes - uptake shifts from VRG to muscle group as VRG saturates
  3. Fat group equilibrates very slowly (hours) - high fat/blood coefficient means fat is a vast reservoir (especially for halothane λfat/blood = 60, isoflurane = 45); prolonged infusion leads to fat accumulation and delayed emergence
  4. VPG essentially negligible uptake
Three-compartment FA/FI curve: The characteristic FA/FI graph shows three "knees" corresponding to successive equilibration of VRG, then muscle, then fat - each time the gradient to the next compartment takes over.

RECOVERY AND EMERGENCE

The same FA/FI concept applies in reverse. Factors speeding recovery:
  • Low blood/gas partition coefficient (desflurane, sevoflurane > halothane)
  • Elimination of rebreathing (high fresh gas flows)
  • Low circuit volume
  • High alveolar ventilation
  • Low fat/blood coefficient - less agent stored in fat compartment
  • Short duration of anaesthesia - less redistribution to fat
Diffusion hypoxia (Fink effect): At termination of N₂O anaesthesia, large volumes of N₂O rapidly diffuse from blood into alveoli, diluting both O₂ and CO₂. This can cause transient hypoxia. Prevention: administer 100% O₂ for 5-10 minutes at end of N₂O anaesthesia.

Summary Table: FA/FI - Factors at a Glance

Factor↑ FA/FI (faster induction)↓ FA/FI (slower induction)
SolubilityLow λb/g (desflurane)High λb/g (halothane)
Cardiac outputLow COHigh CO
Alveolar ventilationHighLow
FRCSmall (child)Large (adult, emphysema)
Inspired concentrationHigh FILow FI
FGF rateHighLow
Circuit volumeSmallLarge
Key References:
  • Barash, Cullen & Stoelting's Clinical Anesthesia, 9th ed., pp.1976-1977 (vaporiser - pumping effect)
  • Miller's Anesthesia, 10th ed., pp.2287-2290 (vaporiser output factors, pumping effect, modifications)
  • Morgan & Mikhail's Clinical Anesthesiology, 7th ed., pp.281-289 (partition coefficients, uptake, concentration effect, tissue distribution)
This is a shared conversation. Sign in to Orris to start your own chat.